Dolby Laboratories' stock experienced a significant after-hours plunge of 6.69% following the release of its second-quarter financial results.
The decline appears to be driven by the company's third-quarter revenue outlook, which fell short of analyst expectations. Dolby provided Q3 revenue guidance of $295 million to $325 million, significantly below the Ibes estimate of $343.5 million.
While the company reported Q2 revenue of $396 million, beating the estimate of $385.8 million, investors focused on the weaker forward-looking guidance, leading to the post-market selloff.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments